Company Monitoring Page for Incyte

job ratings for Incyte

10/25/17
industry:
Biotech
company:
Incyte
job rating:
1
Great product, incompetent impotent leadership. No one at the wheel.
09/11/17
industry:
Biotech/Pharmaceutical
job title:
Sales
company:
Incyte
job rating:
3
Over regulated,incompetent management,

latest headlines for company on cafepharma

Incyte scraps anemia program after drug fails to improve symptoms in rare blood cancer
Fierce Biotech
Sun, 12/15/24 - 10:46 pm
Tags:
Incyte, myelofibrosis, anemia, zilurgisertib
Incyte sinks on setback for drugs acquired in $750M buyout
BioPharma Dive
Tue, 11/19/24 - 07:10 pm
Tags:
Incyte, Escient Pharma, M&A
Incyte blocks US launch of Sun Pharma's alopecia drug
Pharmaphorum
Mon, 11/4/24 - 11:10 am
Tags:
Incyte, Sun Pharma, Leqselvi, alopecia areata
With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end
Fierce Pharma
Wed, 10/30/24 - 11:42 am
Tags:
Incyte, Jakafi, patent cliff, Niktimvo, graft vs host disease, Monjuvi, follicular lymphoma, Zynyz, squamous cell anal carcinoma
ESMO: Even after unique trial win, Incyte CEO views PD-1 drug Zynyz as pipeline aide
Fierce Pharma
Sun, 09/15/24 - 06:27 pm
Tags:
Incyte, Zynyz, ESMO
Incyte and Syndax's immunotherapy for transplant complications receives FDA approval
Biopharma Reporter
Tue, 08/20/24 - 11:49 am
Tags:
Incyte, Syndax, immunotherapy, Niktimvo, graft vs host disease
Armed with Phase III win, Incyte eyes label expansion for Monjuvi
Clinical Trials Arena
Fri, 08/16/24 - 11:19 am
Tags:
Incyte, clinical trials, Monjuvi, relapsed or refractory follicular lymphoma
FDA approves Incyte's treatment for chronic graft-versus-host disease
Reuters
Wed, 08/14/24 - 10:37 pm
Tags:
Incyte, FDA, graft vs host disease, Niktimvo
Incyte drops pair of PD-L1 drugs as part of 2nd pipeline clear-out this year
Fierce Biotech
Tue, 07/30/24 - 11:44 am
Tags:
Incyte, anti-PD-L1
Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state
Fierce Pharma
Tue, 05/21/24 - 06:56 pm
Tags:
Incyte, Delaware, Opzelura
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Tue, 04/23/24 - 09:46 pm
Tags:
Incyte, M&A, Escient Pharma, atopic dermatitis
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Tags:
Incyte, clinical trials, prurigo nodularis, povorcitinib, Dupixent, Sanofi, Regeneron
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Tags:
Synnovation Therapeutics, Incyte, AstraZeneca, GSK, Novartis, Pfizer, funding, cancer, PARP inhibitors
Incyte reports positive data from Phase III vitiligo trial
Clinical Trials Arena
Thu, 10/12/23 - 05:27 pm
Tags:
Incyte, Opzelura, vitiligo, clinical trials
Replimune and Incyte to study cancer combo therapy in CSCC patients
Clinical Trials Arena
Tue, 08/1/23 - 10:06 am
Tags:
Replimmune, Incyte, clinical trials, RP1, CSCC, cutaneous squamous cell carcinoma
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Tags:
Incyte, ruxolitinib, clinical trials, pediatric, atopic dermatitis
Blood cancer trial finds ruxolitinib better than current treatments
Clinical Trials Arena
Fri, 05/5/23 - 10:13 am
Tags:
clinical trials, polycythemia vera, Jakafi, Incyte
Incyte whittles down pipeline, scrapping 6 R&D programs
Fierce Biotech
Tue, 05/2/23 - 11:25 pm
Tags:
Incyte, R7D, anemia, cancer
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
Tags:
biotech, clinical trials, Alnylam Pharmaceuticals, Arcus Biosciences, Argenx, Arrowhead Pharmaceuticals, Axsome Therapeutics, Bavarian Nordic, FibroGen, Gilead Sciences, Incyte, Morphic Therapeutic, PTC Therapeutics, Syndax Pharmaceuticals, Travere Therapeutics, Vaxcyte
Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion
Endpoints
Fri, 03/24/23 - 10:05 am
Tags:
Incyte, FDA, ruxolitinib, CRL

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.